|View printer-friendly version|
Array CEO Robert E. Conway to Speak at the Friedman Billings Ramsey 8th Annual Growth Investor Conference
BOULDER, Colo., May 25 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Friedman Billings Ramsey 8th Annual Growth Investor Conference on June 2 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: Friedman Billings Ramsey 8th Annual Growth Investor Conference Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma Date: Wednesday, June 2, 2004 Time: 3:30 p.m. Eastern Time Location: Millennium Broadway Hotel, New York City Webcast: www.arraybiopharma.com About Array BioPharma:
Array BioPharma is creating the next generation of orally active drugs by integrating the latest advances in chemistry, biology and informatics. Our drug development pipeline is focused primarily in cancer and inflammatory disease and includes several promising small molecule drugs that regulate targets in therapeutically important disease pathways. In addition, Array collaborates with leading pharmaceutical and biotechnology companies to design, create and optimize drug candidates across a broad range of therapeutic areas. Our mission is to be the most efficient inventor of high quality drug candidates in the pharmaceutical industry. For more information on Array, please go to www.arraybiopharma.com.
Array BioPharma Inc.
Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193, firstname.lastname@example.org/
/Web site: http://www.arraybiopharma.com / (ARRY)